Rapidly Progressive (Crescentic) Glomerulonephritis

Overview


Plain-Language Overview

Rapidly Progressive (Crescentic) Glomerulonephritis is a serious kidney condition that affects the tiny filtering units called glomeruli. It causes rapid loss of kidney function over days to weeks, which can lead to dangerous buildup of waste in the body. The disease involves inflammation and damage to the glomeruli, leading to leakage of blood and protein into the urine. This condition primarily affects the renal system and can cause symptoms like swelling, high blood pressure, and decreased urine output. Early detection is critical because the damage can progress quickly and may result in kidney failure if untreated.

Clinical Definition

Rapidly Progressive (Crescentic) Glomerulonephritis (RPGN) is defined by the presence of extensive glomerular crescent formation on kidney biopsy, reflecting severe glomerular injury. It is characterized by a rapid decline in glomerular filtration rate due to aggressive inflammation and proliferation of parietal epithelial cells in Bowman's space. The underlying mechanisms include autoimmune-mediated injury such as anti-glomerular basement membrane antibodies, immune complex deposition, or pauci-immune vasculitis often associated with ANCA antibodies. RPGN is clinically significant because it leads to acute kidney injury and can progress to end-stage renal disease without prompt immunosuppressive treatment. Histologically, the hallmark is the presence of crescents composed of proliferating cells and fibrin in the glomeruli. The condition is a nephrological emergency requiring rapid diagnosis and intervention.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses


Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

Analytics Disclosure: If you allow analytics cookies, Doctogenic uses Google Analytics, Microsoft Application Insights, and Microsoft Clarity to understand site usage, diagnose issues, review heatmaps and session replay recordings, and improve the service on pages where those tools are enabled. Clarity is not enabled on account, purchase, billing, checkout, Stripe-related, or admin pages. You can change this choice through Cookie preferences.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.